Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Phenotype in the heterozygous R98C knock-in mouse model of CMT1B is not improved by neuregulin 1 type III overexpression
Neuromuscular and Clinical Neurophysiology (EMG)
(-)
064
Authors/Disclosures
Yunhong Bai (Department of Neurology, University of Iowa)
PRESENTER
No disclosure on file
Reyna Duron, MD (UCLA/VA Medical Center) No disclosure on file
Chiara Pisciotta No disclosure on file
Suola Wang No disclosure on file
Xingyao Wu (Wayne State University) No disclosure on file
No disclosure on file
Lawrence G. Wrabetz, MD (SUNY Buffalo School of Medicine) No disclosure on file
Michael E. Shy, MD, FÂé¶¹´«Ã½Ó³»­ (University of Iowa) Dr. Shy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Shy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DTx Pharma. The institution of Dr. Shy has received research support from NIH. The institution of Dr. Shy has received research support from Muscular Dystrophy Association. The institution of Dr. Shy has received research support from Charcot Marie Tooth Association. The institution of Dr. Shy has received research support from Applied Therapeutics.